High rate of Ki‐67 increase in entero‐pancreatic <scp>NET</scp> relapses after surgery with curative intent-Reference-Cited by-同舟云学术

High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent

Published:2022-08-24 Issue:10 Volume:34 Page:
ISSN:0953-8194
Container-title:Journal of Neuroendocrinology
language:en
Short-container-title:J Neuroendocrinology

Author:

Merola Elettra¹²^ORCID,Perren Aurel³,Rinke Anja⁴,Zerbi Alessandro⁵⁶,McNamara Mairéad G.⁷,Arsenic Ruza⁸,Fazio Nicola⁹,de Herder Wouter¹⁰,Valle Juan W.⁷,Gress Thomas M.⁴,Wiedenmann Bertram¹¹,Pascher Andreas¹²¹³,Pavel Marianne E.¹¹¹

Affiliation:

1. Department of Medicine 1, Division of Endocrinology Friedrich‐Alexander University Erlangen‐Nuremberg Erlangen Germany

2. Department of Gastroenterology Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari (APSS) Trento Italy

3. Institute of Pathology University of Bern Bern Switzerland

4. Department of Gastroenterology, University Hospital Gießen and Marburg, Marburg, Germany, Department of Surgery Charité Universitätsmedizin Berlin Germany

5. Department of Biomedical Sciences Humanitas University Milan Italy

6. IRCCS Humanitas Research Hospital Milan Italy

7. Division of Cancer Sciences University of Manchester/Department of Medical Oncology, The Christie NHS Foundation Trust Manchester UK

8. Department of Pathology Charité Universitätsmedizin Berlin Germany

9. Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumours European Institute of Oncology IEO, IRCCS Milan Italy

10. Department of Internal Medicine Sector of Endocrinology Rotterdam The Netherlands

11. Department of Hepatology and Gastroenterology Campus Virchow‐Klinikum, Charité Universitätsmedizin Berlin Germany

12. Klinik für Allgemein‐, Viszeral‐ und Transplantationschirurgie, Universitätsklinikum Münster Münster Germany

13. Department of Surgery Campus Virchow‐Klinikum, Charité Universitätsmedizin Berlin Germany

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jne.13193

Reference20 articles.

1. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

2. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

3. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

4. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in histopathological classification and tissue biomarkers of digestive neuroendocrine neoplasms: What the clinician should know;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09

2. Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine Tumors;Cancers;2023-07-21

3. Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time;Journal of Neuroendocrinology;2023-04

4. Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms;Cancers;2023-03-20

5. Spatial and temporal heterogeneity of digestive neuroendocrine neoplasms;Therapeutic Advances in Medical Oncology;2023-01